The non-Responsiveness to Anti-Vascular Endothelial Growth Factor Agents in the Treatment of Neovascularage-Related Macular Degeneration

Abstract

In this editorial, the definition and potential risk factors of the non-responsiveness to the intravitreal applications of anti-vascular endothelial growth factors in the patients with neovascular age-related macular degeneration were summarized. To know the potential risk factors for the non-responsiveness to these agents may prevent unnecessary treatment interventions and unrealistic patient expectations.